GeoVax Labs

Activities: Regulatory Research & Development Pharmaceutical

Trending Articles

  1. Johnson & Johnson completes V-Wave acquisition to support patients with heart failure The strategic acquisition will bolster the pharma giant's MedTech offerings for patients with cardiovascular disease
  2. Merck's MilliporeSigma cuts the ribbon on €290m US biosafety and analytical facility The site will host biosafety testing, analytical development and cell banking manufacturing services
  3. Rousselot Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global...
  4. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  5. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it

Upcoming event

Lab Innovations

30-31 October 2024 | Exhibition | Birmingham, UK See all

Related Content

You need to be a subscriber to read this article.
Click here to find out more.
Pharmaceutical

Zika outbreak gives rise to global fears

Zika may not be a new virus but its newly confirmed ability to cause foetal brain abnormalities makes the search for a treatment or a vaccine a high priority. Dr Sarah Houlton looks at the latest initiatives
Research & Development

Farshad Guirakhoo joins GeoVax as Senior Vice President, Research and Development

US biotechnology firm strengthens its scientific leadership team
Regulatory

GeoVax launches second clinical site to test HIV vaccine

University of Alabama to study effects of vaccine on patients with HIV
Subscribe now